Medications for Panic Disorder
Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for panic disorder due to their efficacy, safety profile, and long-term effectiveness. 1, 2
First-Line Pharmacological Options
SSRIs
Sertraline:
Fluoxetine:
- Starting dose: 10 mg daily
- Target dose: 20-60 mg daily
- Dose should be increased to 20 mg after one week 6
Paroxetine:
SNRIs
- Venlafaxine:
Administration Guidelines
- Initiation: Start at lower doses than those used for depression (e.g., sertraline 25 mg, fluoxetine 10 mg) to minimize initial anxiety/activation 1, 6
- Titration: Increase dose gradually every 1-2 weeks as tolerated 1
- Duration: Treatment should continue for at least 12 weeks to properly evaluate efficacy 7
- Maintenance: Long-term treatment (9-12 months minimum) is often necessary after symptom remission 2
Second-Line Options
Benzodiazepines
- May be used for short-term treatment or in non-responsive cases 2
- Should be avoided in patients with history of substance abuse/dependence 2
- Examples: alprazolam, clonazepam
- Caution: Risk of dependence, tolerance, and withdrawal symptoms 8
Tricyclic Antidepressants
- As effective as SSRIs but with poorer tolerability 2, 9
- Examples: imipramine, clomipramine
- Limitations: Anticholinergic side effects, cardiotoxicity in overdose, delayed onset of action (4-6 weeks) 8
Non-Pharmacological Treatment
Cognitive Behavioral Therapy (CBT) is highly effective for panic disorder:
- As effective as medication for panic disorder 9
- Can be used alone or in combination with medication 9
- Particularly beneficial for long-term outcomes 2
Treatment Algorithm
Initial Treatment:
- Start with an SSRI (sertraline, fluoxetine, or paroxetine) at a low dose
- AND/OR refer for CBT if available
After 4-6 weeks:
- If partial response: Increase SSRI dose within recommended range
- If no response: Switch to a different SSRI or an SNRI
After 12 weeks:
- If good response: Continue treatment for at least 9-12 months
- If inadequate response: Consider adding CBT (if not already initiated) or switching medication class
Treatment-Resistant Cases:
- Consider combination therapy (medication + CBT)
- Consider trial of a TCA or benzodiazepine (short-term)
Important Considerations
- Monitoring: Watch for increased anxiety, agitation, or suicidal ideation, especially during the first few weeks of treatment 1
- Discontinuation: Taper medications gradually (over weeks to months) to avoid withdrawal symptoms, particularly with paroxetine and SNRIs 1, 7
- Comorbidities: Panic disorder frequently co-occurs with depression, other anxiety disorders, and substance use disorders 3
- Drug Interactions: Be aware of potential interactions, especially with SSRIs that affect CYP450 enzymes 1
Special Populations
- Pregnancy/Lactation: Requires careful risk-benefit assessment
- Elderly: Use lower starting doses and titrate more slowly 1
- Hepatic/Renal Impairment: Dose adjustments may be necessary, particularly for fluoxetine and paroxetine 6
By following this evidence-based approach to medication selection and management, most patients with panic disorder can achieve significant symptom reduction and improved quality of life.